We describe a 42-year-old man with AIDS and Hodgkin's lymphoma whose severe and recalcitrant cutaneous warts resolved following treatment with local 1% cidofovir. Clinically significant improvements were observed in a two-week period of therapy. In advanced HIV disease complicated by additional haematological malignancy, cutaneous warts may be difficult to treat and present a challenge for the attending physicians. In similar clinical condition topical anti-human papillomavirus therapy may prove to be safe and curative.
TyringSK.Human papillomavirus infections: epidemiology, pathogenesis, and host immune response.J Am Acad Dermatol2000; 43: S18–26.
2.
CalistaD.Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.J Eur Acad Dermatol Venereol2000; 14: 484–8.
3.
MartinelliC, FareseA, Del MistroA, GiorginiS, RuffinoI.Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection.J Eur Acad Dermatol Venereol2001; 15: 568–9.
4.
De ClercqE.Antiviral drugs in current clinical use.J Clin Virol2004; 30: 115–33.
5.
HivnorC, ShepardJW, ShapiroMS, VittorioCC.Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV.Arch Dermatol2004; 140: 13–4.
6.
GröneD, TreudlerR, de VilliersEM, HusakR, OrfanosCE, ZouboulisChC.Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome.J Eur Acad Dermatol Venereol2006; 20: 202–5.
7.
BienvenuB, MartinezF, DevergieA.Topical use of cidofovir-induced acute renal failure.Transplantation2002; 73: 661–2.
